Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa

被引:26
作者
Kataoka, H
Uchino, H
Denda, K
Kitamura, N
Itoh, H
Tsubouchi, H
Nabeshima, K
Koono, M
机构
[1] Miyazaki Med Coll, Dept Pathol 2, Miyazaki 88916, Japan
[2] Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 226, Japan
[3] Miyazaki Med Coll, Dept Parasitol, Miyazaki 88916, Japan
[4] Miyazaki Med Coll, Dept Internal Med 2, Miyazaki 88916, Japan
关键词
hepatocyte growth factor; hepatocyte growth factor activator; hepatocyte growth factor activator inhibitor; colon cancer;
D O I
10.1016/S0304-3835(98)00067-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gene expression of hepatocyte growth factor activator inhibitor (HAI), a recently identified Kunitz-type serine proteinase inhibitor, was analyzed in a series of human colorectal carcinoma cell lines and in human colorectal tissues. All of the 14 cell lines derived from adenocarcinoma of the colorectum expressed HAI in vitro, whereas a colon carcinoma cell line of neuroendocrine origin did not. In vivo, HAI was consistently expressed in the normal colorectal mucosa, Although the expression of HAI mRNA was conserved in adenocarcinoma tissues of the colorectum, the levels of expression were decreased in the adenocarcinoma tissues compared to the normal counterparts. There was a tendency towards an inverse correlation, albeit not well defined, between the amounts of HAI mRNA and the tumor progression. Immunohistochemical study indicated that HAI protein is present predominantly on the surface of epithelial cells of the colon and the immunoreactivity was decreased in the adenocarcinoma cells. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 41 条
[1]  
BELLUSCI S, 1994, ONCOGENE, V9, P1091
[2]   HEPATOCYTE GROWTH-FACTOR - A MULTIFUNCTIONAL CYTOKINE [J].
BOROS, P ;
MILLER, CM .
LANCET, 1995, 345 (8945) :293-295
[3]  
CALLANDER NS, 1992, CANCER-AM CANCER SOC, V70, P1194, DOI 10.1002/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO
[4]  
2-E
[5]   MOLECULAR-BIOLOGY OF HUMAN PLASMINOGEN .2. METABOLISM IN PHYSIOLOGICAL AND SOME PATHOLOGICAL CONDITIONS IN MAN [J].
COLLEN, D ;
VERSTRAETE, M .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (02) :403-408
[6]   MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE [J].
COOPER, CS ;
PARK, M ;
BLAIR, DG ;
TAINSKY, MA ;
HUEBNER, K ;
CROCE, CM ;
VANDEWOUDE, GF .
NATURE, 1984, 311 (5981) :29-33
[7]  
DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
[8]   DISTRIBUTION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN TUMORS - CONCENTRATION IN TUMOR BLOOD-VESSELS [J].
DVORAK, HF ;
SIOUSSAT, TM ;
BROWN, LF ;
BERSE, B ;
NAGY, JA ;
SOTREL, A ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1275-1278
[9]   PURIFICATION OF SCATTER FACTOR, A FIBROBLAST-DERIVED BASIC-PROTEIN THAT MODULATES EPITHELIAL INTERACTIONS AND MOVEMENT [J].
GHERARDI, E ;
GRAY, J ;
STOKER, M ;
PERRYMAN, M ;
FURLONG, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5844-5848
[10]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419